Dear Colleague,

It is our pleasure to announce we are now organizing Melanoma and Immunotherapy Bridge 2020, on behalf of Fondazione Melanoma Onlus.
Upcoming annual appointments for worldwide cancer clinicians and researchers, gaining more and more attendees every year, the 6th edition of Immunotherapy Bridge and the 11th edition of Melanoma Bridge will take place from December 2nd to 3rd and from December 3rd to 5th, respectively.
Due to the COVID-19 pandemic this year the Bridge will be a VIRTUAL MEETING.
The live streaming is a new opportunity to increase even more the interactive atmosphere and the international participation.
The 2020 edition of both events will be very thrilling!
The scientific program of Immunotherapy Bridge will be focused first on important issues of the biomarkers and will also include a Session jointly organized with SITC.
Hence, the state of the art of immunotherapy from the clinical point of view in various types of malignances will be exhaustively discussed and the final session will be dedicated to the neoadjuvant.
The scientific program of Melanoma Bridge will host a Session dedicated to system biology and targeted therapies development, followed by two sessions aimed at the progresses of melanoma research on biomarkers and on combination strategies, respectively.
Immunotherapy and Melanoma Bridge will end with the Great Debate Session each, in which big topics will be shown and thoroughly discussed from two different points of view.
Attendees are expected from all around the world and encouraged to submit their abstracts for poster or oral presentation during the dedicated sessions of both meetings.
We're looking forward to meeting you again "virtually"!

Paolo A. Ascierto
Corrado Caracò
Bernard A. Fox
Patrick Hwu
Iman Osman
Igor Puzanov

For information please contact